22.01
price up icon2.56%   0.55
 
loading
Schrodinger Inc stock is traded at $22.01, with a volume of 439.95K. It is up +2.56% in the last 24 hours and up +24.49% over the past month. Schrodinger Inc is a healthcare-based software company. Its operating segments are Software and Drug discovery. Through the Software segment, the company is focused on selling software to transform drug discovery across the life sciences industry and customers in materials science industries. In the Drug discovery segment, it is engaged in generating revenue from a portfolio of preclinical and clinical programs, internally and through collaborations. It generates revenue from the sales of software solutions and from research funding and milestone payments from its drug discovery collaborations.
See More
Previous Close:
$21.46
Open:
$21.64
24h Volume:
439.95K
Relative Volume:
0.65
Market Cap:
$1.58B
Revenue:
$188.48M
Net Income/Loss:
$-143.14M
P/E Ratio:
39.30
EPS:
0.56
Net Cash Flow:
$-158.83M
1W Performance:
+14.81%
1M Performance:
+24.49%
6M Performance:
+0.14%
1Y Performance:
-29.39%
1-Day Range:
Value
$21.60
$22.19
1-Week Range:
Value
$18.84
$22.72
52-Week Range:
Value
$16.67
$38.00

Schrodinger Inc Stock (SDGR) Company Profile

Name
Name
Schrodinger Inc
Name
Phone
503-299-1150
Name
Address
1540 BROADWAY, NEW YORK, NY
Name
Employee
787
Name
Twitter
@schrodinger
Name
Next Earnings Date
2024-11-12
Name
Latest SEC Filings
Name
SDGR's Discussions on Twitter

Compare SDGR with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Health Information Services icon
SDGR
Schrodinger Inc
22.01 1.58B 188.48M -143.14M -158.83M 0.56
Health Information Services icon
VEEV
Veeva Systems Inc
226.76 36.93B 2.57B 615.26M 996.76M 3.32
Health Information Services icon
SOLV
Solventum Corp
72.48 12.43B 8.26B 66.00M 1.17B 0.00
Health Information Services icon
TEM
Tempus Ai Inc
62.98 10.01B 640.44M -743.28M -206.93M 0.00
Health Information Services icon
DOCS
Doximity Inc
53.39 9.94B 493.63M 160.55M 162.20M 0.55
Health Information Services icon
HQY
Healthequity Inc
102.47 8.91B 1.10B 105.67M -197.98M 0.1475

Schrodinger Inc Stock (SDGR) Upgrades & Downgrades

Date Action Analyst Rating Change
Jul-02-24 Initiated Leerink Partners Outperform
Dec-05-23 Initiated KeyBanc Capital Markets Overweight
May-05-23 Resumed Piper Sandler Overweight
Dec-19-22 Initiated Goldman Neutral
Mar-01-22 Initiated Citigroup Buy
Nov-19-21 Downgrade Morgan Stanley Overweight → Equal-Weight
Nov-19-21 Initiated Piper Sandler Overweight
Nov-11-21 Downgrade BofA Securities Buy → Neutral
Oct-13-21 Initiated Berenberg Buy
Sep-01-21 Upgrade Morgan Stanley Equal-Weight → Overweight
May-25-21 Initiated Craig Hallum Buy
Nov-23-20 Upgrade BofA Securities Neutral → Buy
Oct-12-20 Upgrade Jefferies Hold → Buy
Mar-02-20 Initiated BMO Capital Markets Outperform
Mar-02-20 Initiated Jefferies Hold
Mar-02-20 Initiated Morgan Stanley Equal-Weight
View All

Schrodinger Inc Stock (SDGR) Latest News

pulisher
Nov 27, 2024

Rubric Capital Management LP Grows Position in Schrödinger, Inc. (NASDAQ:SDGR) - MarketBeat

Nov 27, 2024
pulisher
Nov 27, 2024

Algert Global LLC Has $2.35 Million Position in Schrödinger, Inc. (NASDAQ:SDGR) - MarketBeat

Nov 27, 2024
pulisher
Nov 25, 2024

Massachusetts Financial Services Co. MA Purchases 717,059 Shares of Schrödinger, Inc. (NASDAQ:SDGR) - MarketBeat

Nov 25, 2024
pulisher
Nov 23, 2024

Schrodinger, Inc. (SDGR) Reports Q3 Loss, Misses Revenue Estimates - MSN

Nov 23, 2024
pulisher
Nov 22, 2024

Detailed Analysis of Molecular Modeling for Drug Development - openPR

Nov 22, 2024
pulisher
Nov 22, 2024

Quest Partners LLC Purchases 39,218 Shares of Schrödinger, Inc. (NASDAQ:SDGR) - MarketBeat

Nov 22, 2024
pulisher
Nov 22, 2024

Schrödinger, Inc. (NASDAQ:SDGR) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat

Nov 22, 2024
pulisher
Nov 21, 2024

Schrödinger: Positive Signs Despite The Share Price Decline (SDGR) - Seeking Alpha

Nov 21, 2024
pulisher
Nov 21, 2024

Gates Foundation awards second predictive toxicology grant - Philanthropy News Digest

Nov 21, 2024
pulisher
Nov 20, 2024

Schrödinger to Present at Piper Sandler 36th Annual Healthcare Conference - Business Wire

Nov 20, 2024
pulisher
Nov 20, 2024

Schrödinger’s stock pops as it enters collaboration pact with Novartis worth up to $2.5 billion - MSN

Nov 20, 2024
pulisher
Nov 20, 2024

Schrödinger, Novartis Ink Up-to-$2.3B Collaboration, Software Agreement - Genetic Engineering & Biotechnology News

Nov 20, 2024
pulisher
Nov 20, 2024

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)November 19, 2024 - BioSpace

Nov 20, 2024
pulisher
Nov 20, 2024

SDGRSchrodinger, Inc. Latest Stock News & Market Updates - StockTitan

Nov 20, 2024
pulisher
Nov 19, 2024

Schrödinger, Inc. Receives an Additional $9.5 Million from the Bill & Melinda Gates Foundation - Marketscreener.com

Nov 19, 2024
pulisher
Nov 19, 2024

Schrödinger Awards RSU Grants to New Employees Under Inducement Plan | SDGR Stock News - StockTitan

Nov 19, 2024
pulisher
Nov 19, 2024

Biosimulation Market Dynamics and Future Opportunities | 2024 - openPR

Nov 19, 2024
pulisher
Nov 18, 2024

Schrödinger Broadens and Accelerates Predictive Toxicology Initiative - BioSpace

Nov 18, 2024
pulisher
Nov 16, 2024

Sumitomo Mitsui Trust Group Inc. Increases Stake in Schrödinger, Inc. (NASDAQ:SDGR) - MarketBeat

Nov 16, 2024
pulisher
Nov 15, 2024

Leerink Partnrs Decreases Earnings Estimates for Schrödinger - MarketBeat

Nov 15, 2024
pulisher
Nov 15, 2024

(SDGR) Technical Data - Stock Traders Daily

Nov 15, 2024
pulisher
Nov 14, 2024

Schrodinger Inc (SDGR) Quarterly 10-Q Report - Quartz

Nov 14, 2024
pulisher
Nov 14, 2024

Schrodinger (SDGR): Stock Experiences 5% Decline Amid Market Flu - GuruFocus.com

Nov 14, 2024
pulisher
Nov 14, 2024

Pier 88 Investment Partners LLC Buys 35,120 Shares of Schrödinger, Inc. (NASDAQ:SDGR) - MarketBeat

Nov 14, 2024
pulisher
Nov 14, 2024

Schrödinger Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance

Nov 14, 2024
pulisher
Nov 14, 2024

Midtown-based drug company inks $150M deal with Novartis - Crain's New York Business

Nov 14, 2024
pulisher
Nov 13, 2024

Rubric Capital Management LP Increases Stake in Schrodinger Inc - GuruFocus.com

Nov 13, 2024
pulisher
Nov 13, 2024

Schrödinger, Inc. Provides Earnings Guidance for the Fiscal Year Ending December 31, 2024 - Marketscreener.com

Nov 13, 2024
pulisher
Nov 13, 2024

Schrodinger shares target increased, outperform rating on Novartis deal - Investing.com

Nov 13, 2024
pulisher
Nov 13, 2024

Flare and Schrödinger join multibillion-dollar collaborations - BioWorld Online

Nov 13, 2024
pulisher
Nov 13, 2024

Schrödinger announces collaboration with Novartis - The Pharma Letter

Nov 13, 2024
pulisher
Nov 13, 2024

Schrödinger, Inc. (NASDAQ:SDGR) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 13, 2024
pulisher
Nov 13, 2024

Schrodinger announces expanded license agreement with Novartis - Yahoo Finance

Nov 13, 2024
pulisher
Nov 13, 2024

Baillie Gifford & Co. Has $36.75 Million Stock Position in Schrödinger, Inc. (NASDAQ:SDGR) - MarketBeat

Nov 13, 2024
pulisher
Nov 13, 2024

Market Participants Recognise Schrödinger, Inc.'s (NASDAQ:SDGR) Revenues Pushing Shares 26% Higher - Simply Wall St

Nov 13, 2024
pulisher
Nov 13, 2024

Earnings call: Schrödinger reports dip in Q3 revenue, eyes Novartis deal - Investing.com UK

Nov 13, 2024
pulisher
Nov 13, 2024

Schrodinger Inc (SDGR) Q3 2024 Earnings Call Highlights: Navigat - GuruFocus.com

Nov 13, 2024
pulisher
Nov 13, 2024

Schrodinger Inc (SDGR) Q3 2024 Earnings Call Highlights: Navigating Revenue Challenges and ... By GuruFocus - Investing.com Canada

Nov 13, 2024
pulisher
Nov 13, 2024

Schrodinger Inc (SDGR) Q3 2024 Earnings Call Highlights: Navigating Revenue Challenges and ... - Yahoo Finance

Nov 13, 2024
pulisher
Nov 12, 2024

Schrödinger Reports Q3 2024 Earnings and New Novartis Collaboration - TipRanks

Nov 12, 2024
pulisher
Nov 12, 2024

Schrödinger secures Novartis deal with potential $2.3 billion payout By Investing.com - Investing.com Australia

Nov 12, 2024
pulisher
Nov 12, 2024

Schrödinger gains on Novartis deal despite Q3 miss - MSN

Nov 12, 2024
pulisher
Nov 12, 2024

Blade Air Mobility Delivers Q3 Earnings Beat And Strong Margins As Restructuring Takes Flight - AOL

Nov 12, 2024
pulisher
Nov 12, 2024

Schrodinger Inc (SDGR) Stock Price Up 13.36% on Nov 12 - GuruFocus.com

Nov 12, 2024
pulisher
Nov 12, 2024

Schrödinger Scores Big Despite Q3 Miss As Novartis Collaboration Promises Billions In Milestones: Details - Yahoo Finance

Nov 12, 2024
pulisher
Nov 12, 2024

Schrödinger surges on Novartis collaboration agreement - ShareCast

Nov 12, 2024
pulisher
Nov 12, 2024

Market news - Research the market

Nov 12, 2024
pulisher
Nov 12, 2024

Schrödinger, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 12, 2024
pulisher
Nov 12, 2024

Schrödinger secures Novartis deal with potential $2.3 billion payout - Investing.com

Nov 12, 2024
pulisher
Nov 12, 2024

Schrödinger enters collaboration pact with Novartis worth up to $2.5 billion - MarketWatch

Nov 12, 2024
pulisher
Nov 12, 2024

Schrödinger Reports Third Quarter 2024 Financial Results - Business Wire

Nov 12, 2024

Schrodinger Inc Stock (SDGR) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$22.95
price up icon 0.88%
health_information_services WGS
$79.43
price down icon 1.35%
$21.66
price up icon 0.74%
$19.05
price up icon 1.65%
health_information_services WAY
$30.59
price down icon 0.91%
health_information_services HQY
$102.47
price down icon 1.06%
Cap:     |  Volume (24h):